The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

A ketogenic diet may improve symptoms of depression, according to a new review and meta-analysis published in JAMA Psychiatry ...

The ketogenic diet significantly improves symptoms in epilepsy, schizophrenia, as well as in alcohol use disorder, opioid use ...

It’s not just mania that affects your finances. Bipolar depression can also impact your spending patterns, often in ways you ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

New findings reported in JAMA Network Open from a longitudinal cohort study utilizing electronic health records (EHRs) show that individuals with a prior serious mental illness (SMI), including ...

The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday.

Lumateperone is approved as an adjunctive treatment for MDD, expanding its indications beyond schizophrenia and bipolar ...

Rapper Gucci Mane has spoken out about his mental health after being diagnosed with schizophrenia and bipolar disorder. The singer and his wife, Keyshia Ka’oir, chatted about his health during ...